CXCR4, une cible thérapeutique dans certains déficits immunitaires rares?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCR4, une cible thérapeutique dans certains déficits immunitaires rares?

Published:2011-04 Issue:4 Volume:27 Page:391-397
ISSN:0767-0974
Container-title:médecine/sciences
language:
Short-container-title:Med Sci (Paris)

Author:

Bignon Alexandre,Biajoux Vincent,Bouchet-Delbos Laurence,Emilie Dominique,Lortholary Olivier,Balabanian Karl

Publisher

EDP Sciences

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.medecinesciences.org/10.1051/medsci/2011274015/pdf

Reference26 articles.

1. Moving targets: cell migration inhibitors as new anti-inflammatory therapies

2. CXCR4, un récepteur de chimiokine aux multiples talents

3. Regulation of CXCR4 signaling

4. The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes

5. Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiopathic CD4 lymphocytopenia;Allergy and Asthma Proceedings;2016-11-01

2. Involvement of CXCL12 Pathway in HPV-related Diseases;AIMS Medical Science;2016

3. WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear;Annales de biologie clinique;2014-01

4. La chimiokine CXCL12 et le papillomavirus humain;médecine/sciences;2011-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3